Market revenue in 2023 | USD 294.5 million |
Market revenue in 2030 | USD 396.9 million |
Growth rate | 4.4% (CAGR from 2023 to 2030) |
Largest segment | Peripheral stents |
Fastest growing segment | Peripheral Stents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | PTA Balloons, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Peripheral Accessories, Inferior Vena Cava Filters, Hemodynamic Flow Alteration Devices, Peripheral Stents |
Key market players worldwide | Abbott Laboratories, Edwards Lifesciences Corp, Medtronic PLC, St. Jude Medical, Teleflex Inc, Philips, Boston Scientific Corp, Cook Group, Covidien, AngioScore |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to peripheral vascular devices market will help companies and investors design strategic landscapes.
Peripheral stents was the largest segment with a revenue share of 48.56% in 2024. Horizon Databook has segmented the Canada peripheral vascular devices market based on pta balloons, catheters, endovascular aneurysm repair stent grafts, plaque modification devices, peripheral accessories, inferior vena cava filters, hemodynamic flow alteration devices, peripheral stents covering the revenue growth of each sub-segment from 2018 to 2030.
Advancements in medical technology, such as the evolution of minimally invasive procedures and cutting-edge device designs, contribute to market expansion through enhanced treatment efficacy and accelerated patient recovery. The presence of well-established healthcare infrastructure, encompassing hospitals and specialized clinics, is expected to boost the adoption of peripheral vascular devices in Canada.
The competitive dynamics in Canada peripheral vascular devices market are significantly influenced by the presence of key domestic and international medical device enterprises. Moreover, rising regulatory approval for peripheral vascular devices is boosting the market growth.
For instance, in January 2022, Cook received breakthrough device designation by the U.S. FDA for a novel drug-eluting stent intended for use Below The Knee (BTK). This innovative stent is specifically engineered to address the needs of individuals suffering from Chronic Limb-Threatening Ischemia (CLTI), which is an advanced PAD.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada peripheral vascular devices market, including forecasts for subscribers. This country databook contains high-level insights into Canada peripheral vascular devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account